VANECK ETF TRUST - BIOTECH ETF (BBH)

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / BIOTECH ETF
Number of holders
102
Total 13F shares, excl. options
811,222
Shares change
-15,982
Total reported value, excl. options
$131,452,614
Value change
-$2,603,942
Put/Call ratio
60%
Number of buys
35
Number of sells
38
Price
$162.08

Institutional Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q3 2020

As of 30 Sep 2020 VANECK ETF TRUST - BIOTECH ETF (BBH) had 116 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 811,222 shares of stock of the company.
Largest 10 holders included Pinnacle Advisory Group, Inc., MORGAN STANLEY, ROYAL BANK OF CANADA, GOLDMAN SACHS GROUP INC, UBS Group AG, Kestra Advisory Services, LLC, MURPHY CAPITAL MANAGEMENT INC, BANK OF AMERICA CORP /DE/, MOGY JOEL R INVESTMENT COUNSEL INC, and LPL Financial LLC.
This table shows 116 institutional shareholders of the security as of 30 Sep 2020.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.